EFFECTS OF LOW MOLECULAR WEIGHT HEPARIN VERSUS DABIGATRAN ON PLATELET AGGREGATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE

EFFECTS OF LOW MOLECULAR WEIGHT HEPARIN VERSUS DABIGATRAN ON PLATELET AGGREGATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE

Conclusions: Dabigatran increases platelet activation and aggregation promoted by thromboxane in patients with coronary artery disease on aspirin when compared to enoxaparin.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2017-03, Vol.69 (11), p.208-208
Hauptverfasser: Arantes, Flavia Bittar Britto, Menezes, Fernando, Franci, Andre, Barbosa, Carlos, Dalçoquio, Talia F, Nakashima, Carlos K, Ferrari, Aline, Filho, Marco Scanavini, Furtado, Remo, Baracioli, Luciano, Ramires, Jose, Kalil-Filho, Roberto, Nicolau, Jose
Format: Artikel
Sprache:eng
Schlagworte:
Blood platelets
Cardiac arrhythmia
Cardiology
Cardiovascular
Cardiovascular disease
Coronary vessels
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Conclusions: Dabigatran increases platelet activation and aggregation promoted by thromboxane in patients with coronary artery disease on aspirin when compared to enoxaparin.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(17)33597-0